Xenetic Biosciences, Inc. (XBIO)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
As of 04:00PM EDT. Market open.
| Previous close | 3.9000 |
| Open | 3.8100 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 3.9600 - 3.9600 |
| 52-week range | 2.5500 - 5.9700 |
| Volume | |
| Avg. volume | 5,631 |
| Market cap | 6.101M |
| Beta (5Y monthly) | 2.67 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Xenetic Biosciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Xenetic Biosciences ( NASDAQ:XBIO ) Full Year 2023 Results Key Financial Results Revenue: US$2.54m (up 49% from FY...
- Simply Wall St.
Most Shareholders Will Probably Agree With Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation
Key Insights Xenetic Biosciences will host its Annual General Meeting on 6th of December Total pay for CEO Jeff...
- Zacks
Xenetic Biosciences (XBIO) Reports Q2 Loss, Tops Revenue Estimates
Xenetic Biosciences (XBIO) delivered earnings and revenue surprises of 38.94% and 47.96%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.